Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 2013. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of a specific share transaction rather than a financial performance report.
Material Changes
The filing details a transaction on December 10, 2013, involving Mr. P C Thomson and his connected person, Mrs. K Thomson. Through the Company's ShareReward Plan, the following acquisitions occurred:
- Acquisition of 2 Ordinary Shares under the personal contribution element.
- Acquisition of 2 Ordinary Shares under the matching element (Company contribution).
The purchase price was 1594.287 pence per Ordinary Share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the share transaction in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).
Key Facts for Investor Verification
- Transaction Date: December 10, 2013.
- Parties Involved: Mr. P C Thomson (Director/PDMR) and Mrs. K Thomson (Connected Person).
- Share Count: Total of 4 Ordinary Shares acquired (2 personal, 2 company match).
- Price per Share: 1594.287 pence.
- Plan Type: ShareReward Plan.